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Background. The biochemical characteristics of keloid-derived fibroblasts differ from those of adjacent normal fibroblasts, and
these differences are thought to be the cause of abnormal fibrosis. Therefore, we investigated the characteristic proteins that are
differentially expressed in keloid-derived fibroblasts using proteomics tools. Objective. We attempted to investigate the novel
proteins that play important roles in the pathophysiology of keloids. Methods. Proteomics analysis was performed to identify
differentially expressed proteins in keloid-derived fibroblasts. Keloid-derived fibroblasts and adjacent normal fibroblasts were
analyzed with 2-DAGE. We validated these proteins with immunoblot analysis, real-time RT-PCR, and immunohistochemistry.
Results. Sixteen differentially expressed protein spots were identified in keloid-derived fibroblasts. Among them, heat shock protein
70 (Hsp70) was specifically upregulated in keloid-derived fibroblasts. Also, immunohistochemistry and western blot analysis
revealed increasedHsp70, TGF-𝛽, and PCNAexpressions in keloids compared to normal tissue.Conclusion.Hsp70 is overexpressed
in keloid fibroblasts and tissue. The overexpression of Hsp70 may be involved in the pathogenesis of keloids, and the inhibition of
Hsp70 could be a new therapeutic tool for the treatment of keloids.
1. Introduction
Keloids are pathologic proliferations of the dermal layer of
the skin that result from excessive collagen production and
deposition.With respect to their pathogenesis, various expla-
nations including ischemic [1], mechanical [2], hormonal
[3], autoimmune [4], and genetic theories [5] have been
suggested. In keloids, the homeostasis of wound healing is not
maintained, resulting in excessive synthesis of extracellular
matrix components such as collagen, fibronectin, elastin,
and proteoglycans [6–8]. Additionally, compared to normal
dermal fibroblasts, keloid fibroblasts react differently to
metabolic factors that regulate apoptosis [9], extracellular
matrix metabolism, glucocorticoids, growth factors [10, 11],
and phorbol esters [12].These abnormal fibroblasts have been
considered to be the cause of the abnormal scarring that
occurs with keloids, hypertrophic scars, and pathologic organ
fibrosis.
Proteomics can be used to separate proteins by two-
dimensional electrophoresis (2-DE) and to characterize pro-
teins using several analytical tools. The major advantage of
this proteomic technology is that it allows for the analysis of
the whole protein and studies differentially expressed protein
instead of analyzing each individual proteins separately.
Therefore, studies in the complete proteome level can lead us
to characterize and understand the unknown events involved
in the biological process. With this advantage, proteomics
have been recently used in wide range of dermatologic field,
such as aging, cancer, andUV influence. Two separate studies
previously investigated keloid tissue and normal skin to
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Table 1: Profiles of keloid tissues, fibroblasts, and adjacent normal fibroblasts from the same patients.
No. Sex Age Origin Others
1 M 34 Chest Proteomics
2 F 23 Earlobe Proteomics
3 F 22 Chest qPCR, WB
4 F 22 Axilla qPCR, WB
5 F 19 Shoulder qPCR, WB
6 F 29 Earlobe qPCR, WB
7 M 25 Neck qPCR
8 F 12 Foot qPCR
9 F 4 Buttock qPCR, WB
10 F 48 Earlobe qPCR, WB
11 F 41 Neck qPCR, WB
12 M 10 Arm qPCR, WB
13 F 51 Chest IHC
14 M 71 Chest IHC
15 M 71 Chest IHC
16 M 71 Arm IHC
17 F 35 Earlobe WB
compare their protein profiles [13, 14]. In this study, we
compared primary cultured fibroblasts fromkeloid tissue and
normal skin instead of comparing tissue extracts.We hypoth-
esize that different protein expression profiles in keloid
fibroblasts can provide novel information of keloid pathogen-
esis. By comparing fibroblasts, we attempted to characterize
keloid fibroblasts specifically from normal fibroblasts. Then,
we confirmed the expression of keloid fibroblast-specific
proteins using immunohistochemistry, western blots, and
quantitative RT-PCR.
2. Materials and Methods
2.1. Patients and Sample Collections. After obtaining
informed consent according to a protocol approved by the
Yonsei University College of Medicine Institutional Review
Board, keloid tissues were obtained for fibroblast culture
and immunohistochemistry with excision. Keloid fibroblasts
and normal fibroblasts were obtained from both the central
dermal layer of keloids and the adjacent normal dermis
from patients with keloids in the active stage (Table 1). All
experiments involving humans were performed in adherence
with the Helsinki Guidelines. Keloids were identified by
trained clinicians and pathologists.
2.2. Fibroblast Culture. Primary fibroblasts and HDF cells
(PCS-201-010, ATCC, Manassas, VA, USA) were cultured
in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO,
Grand Island, NY, USA) and supplemented with heat-inacti-
vated 10% fetal bovine serum (FBS), penicillin (30U/mL),
and streptomycin (300 𝜇g/mL). When the primary culture
became confluent, the culturemedium in the primary culture
flasks was removed, and the cells were washed with PBS,
detached completely by adding 2mL of 0.025% trypsin, and
then collected. All cells used in this study were collected
before Passage 5.
2.3. 2𝐷 Electrophoresis. Keloid fibroblasts and normal fibrob-
lasts were washed with PBS, collected with a cell scraper,
centrifuged, and then the pellets were collected. Pellets
were diluted with sample buffer containing 7M urea, 2mM
thiourea, 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS), 2mM tributylphosphine (TBP),
0.5% carrier ampholytes, 40mMTris, and 0.001% bromophe-
nol blue (BPB). An immobilized pH gradient (IPG) was cre-
ated with pH 4–7 strips that were rehydrated and was added
to a sample cup.Then, 350 𝜇L of each sample was centrifuged
and loaded onto the strip. To prevent recrystallization of
urea, 2mL of covering fluid was added, and the samples
were rehydrated at room temperature for approximately 12
hours. The samples were put onto the IPG strips using an
IPGphor isoelectric focusing (IEF) apparatus (Amersham
Pharmacia Biotech, Piscataway, NJ, USA) at 20∘C. The IEF
was conducted at up to 8000V for 64 kVh. After IEF,
each strip was shaken lightly in 20mM Tris-HCl (pH 8.8)
containing 6M urea, 2% SDS, 20% glycerol, 2.5% acrylamide,
and 5mM TBP for 15 minutes to equilibrate samples for
SDS-PAGE. The gradient of polyacrylamide gel (23 × 20 ×
0.1 cm) used in this experiment was 8–16%. Each IPG strip
containing a focused sample was placed on a gel and sealed
in place with SDS containing 0.5% low melting point agarose
and 0.001% BPB. Electrophoresis was performed using ISO-
DALT equipment (Hoefer, San Francisco, CA, USA) for
approximately 19 hours at 100V until the dye reached the
bottom of the gel. The gel was destained with 10% methanol
and 7%acetic acid for 4 hours, then the gel imagewas scanned
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using a GS-800 calibrated densitometer (Bio-Rad, Munich,
Germany).The scanned images were analyzed using Melanie
III 2D electrophoresis analysis software (ver. XX, Bio-Rad).
2.4. In Situ Digestion and MALDI-TOF MS. After excising
the protein spots from the gels, the spots were washed with
25mMammoniumbicarbonate (pH 7.8) and 50% acetonitrile
(ACN) solution and dried using a SpeedVac evaporator. For
each protein sample containing gel residue, 10 𝜇L of 0.02 g/L
trypsin was added, and the mixture was incubated on ice
for 45 minutes. Then, 50mM ammonium bicarbonate buffer
was added again (pH 7.8), and the mixture was incubated at
37∘C for 12–14 hours. To facilitate the extraction of peptides,
10 𝜇L of 0.5% TFA and 50% ACN were added, and the
mixture was sonicated 3 times for 10 minutes. The extracted
peptide samples were spotted on a target plate and completely
dried at room temperature. MALDI-TOF MS results were
obtained on aVoyager-DESTIRmass spectrometer (PerSpec-
tive Biosystems, Framingham, MA, USA). Peptide matching
and protein searches against the NCBI nonredundant pro-
tein database were performed using the ProFound program
(http://prowl.rockefeller.edu). For screening the search data,
only peptides yielding larger than aminimumEst’d Z score of
1.645 were accepted as having extensive homology.
2.5. Western Blot Analysis to Evaluate Hsp70. Cells were
transferred to a micro centrifuge tube and centrifuged for
2 minutes at 3000 rpm. The remnant cells were used as
a cell lysate. RIPA buffer (10mMPBS, 1%NP40, 0.5% sodium
deoxycholate, 0.1% SDS) containing proteinase inhibitors
(10mL/mL PMSF (10mg/mL), 30mL/mL Aprotinin (Sigma,
cat#A6279) and 10mL/mL sodiumorthovanadate (100mM))
was added, and the cells were lysed. We then added
electrophoresis loading buffer (1.0mL glycerol, 0.5mL 2-
mercaptoethanol, 3.0mL 10% SDS, 1.25mL 1.0M Tris-Hcl
(pH 6.7), 1-2mg BPB) to the samples and boiled the samples
for 3 minutes. After 10% SDS-PAGE, the proteins were trans-
ferred to a nitrocellulose membrane (Millipore Co., Bedford,
MA, USA) for 2 hours in a container filled with transfer
buffer solution. The membrane was blocked with 5% normal
fibroblasts at skim milk in 10mM Tris buffered saline (TBS,
pH 8.0) containing 0.05% Tween 20, and antibody against
Hsp70 (Stressgen, BC, Canada), which was diluted to 1 : 1000,
was added. The membrane was then thoroughly washed,
and immunocomplexes were detected using an enhanced
horseradish peroxidase/luminol chemiluminescence system
(ECLPlus, Amersham International plc, Little Chalfont, UK),
followed by autoradiography (Hyperfilm ECL, Amersham
International plc). Immunoblot signals were quantified using
a computer imaging program (GelScopeTM, Imageline Inc.,
CA, USA).
2.6. Quantitative Real-Time Reverse Transcription-Polymerase
Chain Reaction (qRT-PCR). Total RNA was prepared with
the RNeasy Mini Kit (Qiagen, Germany), and comple-
mentary DNA was prepared from 1 𝜇g of total RNA by
anchored-oligo (dT)
18
primer using a Transcriptor First
Strand cDNA Synthesis Kit (Roche, Germany) under the fol-
lowing conditions: 65∘C for 10min, 50∘C for 1 hr, and 85∘C for
5min. Applied Biosystems Taqman primer/probe kits (assay
ID: Hs00359163 s1∗ (Hsp70)) were used to analyze mRNA
expression levels with the use of an Applied Biosystems 7500
Real-Time PCR System (Applied Biosystems, Foster City, CA,
USA). TargetmRNA levels weremeasured relative to an inter-
nal glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
control (assay ID: Hs99999905 m1, Applied Biosystems).
For cDNA amplification, AmpliTaqGold DNA polymerase
was activated after 2min incubation at 50∘C followed by
activation at 95∘C for 10min; this was followed by 50 cycles
of 15 sec activation at 95∘C and 1min at 60∘C for each
cycle. To measure cDNA levels, the threshold cycle at which
fluorescence was first detected above baseline was used, and
a standard curve was drawn between the starting nucleic
acid concentrations and the threshold cycle. The mRNA
expression levels were normalized to the levels of GAPDH
housekeeping genes. Each experiment was performed three
times.
2.7. Immunohistochemical Assessment in Tissues. Immuno-
histochemistry (IHC) was performed in 10% formalin-fixed,
paraffin-embedded keloid tissues. Tissues were pretreated
with a 3% hydrogen peroxide solution for 10 minutes, washed
again with DW several times for 10 minutes each, and
incubated with 1xTBST (TBS + 0.1% Tween 20) for 5minutes.
Tissues were then treated with normal goat serum (Vector
Laboratories, Inc., USA) at room temperature for 1 hour to
prevent nonspecific reactions and incubated overnight with
mouse anti-Hsp70 (ab6535, Abcam, UK) antibody and anti-
TGF-𝛽 (GTX110630, Gene Tex Inc., San Antonio, TX) diluted
to 1 : 100. The tissues were then washed with 1xTBST and
incubated for 30 minutes at room temperature with biotiny-
lated secondary antibody solution from the Dako REAL
EnVision Detection System (Dako, Denmark), washed with
distilled water, counterstained with hematoxylin (SIGMA-
ALDRICH, Inc., USA), dehydrated and clarified by a conven-
tional method, and prepared for examination under a light
microscope. The expression levels of Hsp70 and TGF-𝛽 were
semiquantitatively analyzed using MetaMorph image analy-
sis software (Universal Image Corp.). Results are expressed as
the mean optical density of six different digital images.
2.8. Statistical Analysis. The results obtained were analysed
by paired 𝑡-test and one-way ANOVA. All data were sum-
marized as mean ± standard deviation (SD). Deviations were
considered statistically significant when 𝑃 < 0.05.
3. Results
3.1. Heat Shock 70 kDa Protein 1A Was Upregulated in Keloid
Fibroblasts. Using primary cultured keloid fibroblasts and
normal fibroblasts from two patients, we extracted total
protein, completed 2-DE within the pH 4–7 linear range.
Approximately 800 spots were revealed by image analysis
with Melanie III. Using MALDI-TOF MS, we identified
final 16 protein spots which were consistently increased or
decreased in both patients (Figure 1, Table 2). Heat shock
70 kDa protein 9B (also known as Hsp70-9B or mortalin),
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Figure 1: 2DE proteomic profiles of total protein extracts from normal fibroblasts (a, b) and keloid fibroblasts (c, d). Alphabets and numbers
indicate proteins identified by MALDI-TOF and ProFound program. Further information on each protein is provided in Table 2.
vimentin, dnaK-type molecular chaperone HSPA1L (also
known as Heat shock 70 kDa protein 1L, Hsp70-1L), and
dihydropyrimidinase-like 2 were only detectable in keloids
and crocalbin-like protein, calumenin, vimentin, BiP (also
known as Hsp70-5, GRP78), tropomyosin 1, and heat shock
70 kDa protein 1A (also known as Hsp70-1A) were upregu-
lated in keloids. Among these proteins, several heat shock
proteins (HSPs) were found to be differentially expressed
in keloid fibroblasts, and upregulated HSPs were all Hsp70
families.
3.2. Overexpression of Hsp70 in Keloid Fibroblasts Was Con-
firmed by qRT-PCR and Western Blot. In primary keloid
fibroblasts, the mRNA expression of Hsp70 was exam-
ined using real-time reverse transcription-polymerase chain
reaction (RT-PCR). The quantitative analysis indicated that
the Hsp70 mRNA level in keloid fibroblasts was markedly
increased (𝑃 < 0.05) (Figure 2(a)) compared to HDF. Also,
immunoblot data showed that protein level of Hsp70 was
significantly increased in keloid fibroblasts compared to the
HDF (Figure 2(a)). Both RT-PCR and western blot showed
that all keloid fibroblasts highly expressed Hsp70 than HDF.
From these results, we found that Hsp70 is overexpressed in
all keloid fibroblasts in mRNA and protein level.
3.3. Hsp70 Protein Expression Was Significantly Elevated
in Keloid Tissues. To evaluate the expression pattern of
Hsp70 in keloid tissue, immunohistochemical staining with
anti-Hsp70 monoclonal antibody was carried out. H&E
staining and TGF-𝛽 immunohistochemical staining were
also performed to see the expression pattern compare with
Hsp70. Compared to normal dermis, markedly increased
immunopositivity for Hsp70 was noted in keloid region.
With H&E staining, we found that keloid tissue had a
dense and excessive deposition of collagen in the dermis
alongwithHsp70 expression.Another interesting findingwas
extension of Hsp70 positive cells and dense collagen fiber
over the clinical keloid margin (Figure 3). When obtaining
keloid specimen, we excised extruding keloid mass along
with 3∼5mm normal tissue. Upon histological examination
even the area which looked like normal tissue on gross
view showed Hsp70 positive cells along with dense collagen
BioMed Research International 5
Table 2: Results of the qualitative and quantitative analyses of 2DE performed in keloid fibroblasts and adjacent normal fibroblasts.
Spot no. Identified protein Accessionnumber
Sequence
coverage
(%)
Theoretical
Mr (KDa)/pI
Measured
Mr (KDa)/pI
Est’d
Z Characteristics
B8 Heat shock 70 kDa protein9B NP-004125 23 5.7/70 5.9/74.02 1.68 Keloid-specific
B12 Vimentin A25074 20 4.9/44 5.1/53.7 1.79 Keloid-specific
B16 DnaK-type molecularchaperone HSPA1L A29160 24 5.7/70 5.4/70.21 2.16 Keloid-specific
B19 Dihydropyrimidinase-like 2 NP-001377 20 6.5/60 6/62.84 1.67 Keloid-specific
B-IN1 Crocalbin-like protein AAF76141 38 4.3/40 4.4/34.97 1.71 Upregulated in keloid
Calumenin AAK72908 36 4.4/37.26 Upregulated in keloid
B-IN2 Vimentin NP-003371 29 4.9/45 5.1/53.74 2.3 Upregulated in keloid
B-IN3 BiP protein AAF13605 23 5/75 5.2/71.06 2.15 Upregulated in keloid
A11 Proteasome alpha 6 subunit NP-002782 27 6.6/28 6.3/27.95 2.37 Does not exist in keloid
A-DE1 Tropomyosin 1 A23562 28 5/40 4.6/33.04 2.34 Upregulated in keloid
A-DE3 Heat shock 70 kDa protein1A NP-005336 27 5.7/70 5.5/70.38 2.32 Upregulated in keloid
A-IN1 Vimentin AAA61279 39 5/55 5/53.77 2.35 Downregulated in keloid
A-IN2 Vimentin NP-003371 37 5/55 5.1/53.74 2.39 Downregulated in keloid
A-IN4 Vimentin A25074 30 5.1/55 5.1/53.7 2.35 Downregulated in keloid
A-IN6
Tropomyosin 4-anaplastic
lymphoma kinase fusion
protein
AAK17926 12 5/40 4.9/36.78 2.06 Downregulated in keloid
A-IN11 Endoplasmic reticulumprotein 29 precursor NP-006808 28 6/29 6.8/29.05 2.09 Downregulated in keloid
A-IN12 Heat shock 27 kDa protein 1 NP-001531 33 6.1/26 6/22.84 2.35 Downregulated in keloid
bundle (extended region). Among the most well-known
growth factors in keloid pathogenesis, TGF-𝛽 expression was
also increased in both keloid region and extended dermal
fibrosis region (Figure 3). The increased expression of Hsp70
was quantitatively measured withMetaMorph image analysis
software (Universal Image Corp.) and found to be statistically
significant in both central keloid region and extending
dermal fibrosis (𝑃 < 0.01) (Figure 4). There was no statistical
significant difference between central keloid and extending
region; however, it seems that Hsp70 was even more highly
expressed in extending region than central keloid region.
3.4. Proliferating ActivityWas Significantly Increased in Keloid
Fibroblasts Compared toNormal Fibroblasts. To evaluate pro-
liferating activity in keloid fibroblasts, a PCNA immunohis-
tochemical staining was performed on sections from keloid
tissues. Compared to normal dermis, markedly increased
immunopositivity for PCNA was noted in central keloid
region and also in extended region (Figure 5). Increased
PCNA expression was strongly correlated with the TGF-𝛽
and Hsp70 expression.
4. Discussion
High-throughput screening using proteomics techniques
facilitates the identification of protein interactions and allows
for the analysis of differences in protein expression between
keloid fibroblasts and normal fibroblasts. Using these exper-
iments, it is possible to comprehensively understand the
keloid pathogenesis [13, 14] and to find novel proteins which
might have important role in abnormal fibrosis process.
In this study, through proteomics technology we found 16
differentially expressed protein spots. Among these proteins,
five Hsp chaperone molecules were up-regulated or down-
regulated in keloid fibroblasts. Hsp70-1A, Hsp70-1L, Hsp70-5
and Hsp70-9b were up-regulated or specifically expressed in
keloid fibroblasts and Hsp27 was down regulated in keloid
fibroblasts. We therefore performed further evaluation for
Hsp70 which is known to be highly inducible in stressful
conditions and acts as a molecular chaperon which protects
cells from abnormal protein aggregation [15, 16].
Our results showed consistently increased Hsp70 in
keloid fibroblasts and keloid tissues. Increased Hsp70 expres-
sion was correlated with increased expression of Hsp70 and
TGF-𝛽. Furthermore two of four keloid tissues have collagen
fibers which seem to penetrate to the adjacent normal tissue
over the clinical keloid margin.
Heat shock protein is a highly conserved protein which is
expressed constantly or inducible under the various physio-
logical and environmental stresses. Hsps have protective roles
to the encountered stressors and also important regulatory
roles in the control of apoptosis [17, 18]. They are classified
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Figure 2: Identification of Hsp70. (a) The expression of Hsp70
mRNA was specifically elevated in keloid fibroblasts. (b) Increased
Hsp70 in keloid fibroblasts was confirmed by western blot analysis.
in subgroups by their molecular weight. Recently Hsp47 has
been reported to be upregulated in keloid fibroblasts and
could induce excessive collagen accumulation by enhancing
synthesis and secretion of collagen [19]. Hsp70 family is
one of the most prominent and best characterized stress
proteins [20]. Because keloid fibroblasts are under hypoxic
and hypermetabolic status [7, 21–23], we hypothesized that
there might be a close relationship between Hsp70 and
excessive collagen accumulation in keloid formation.
Hsp70 is an important regulator in apoptosis process. It
inhibits key effectors of the apoptotic cascades such as the
apoptosome, the caspase activation complex, and apoptosis-
inducing factor (AIF) [24, 25]. Also, it is well known that
the antiapoptotic effects of Hsp70 are proposed to occur by
inhibiting the release of cytochrome c from themitochondria
and preventing the activation of caspase-3 [24–26]. Recent
studies have shown that keloid lesions are found to have
lower rates of apoptosis (22% decrease) than normal skin
[27, 28], and cultured keloid fibroblasts have decreased levels
of apoptosis regulatory proteins and apoptosis itself [7, 9, 18].
Other studies have reported that Hsp70 is overexpressed in
keloid tissues. Totan et al. [29] showed increased expression
of Hsp27, Hsp47, and Hsp70 in keloid tissue sample, and
Javad and Day [13] showed increased expression of Hsp60
and Hsp70 through a protein profiling using keloid tissue.
Supporting these reports we achieved similar results from
cultured fibroblasts.
In this study, we found that Hsp70 is significantly
increased in keloid and keloid tissues. Using PCNA stain-
ing, we showed increased proliferative activity of keloid
fibroblasts than adjacent normal fibroblasts. Increased PCNA
staining region was also highly expressed Hsp70 and TGF-
𝛽. Furthermore, thick collagen bundles were located along
with these overexpressed staining patterns. Thus, we suggest
that overexpression of Hsp70 may have an important role
in keloids by protecting keloid fibroblasts from hypoxia and
hypermetabolic status.
Another interesting findingwas infiltrating thick collagen
bundle over the clinical keloid margin. This region also
showed strong positivity with Hsp70, TGF-𝛽, and PCNA
staining, and it was even stronger than keloid center. Clin-
ically, keloids tend to overgrow from original scar having
a tumor-like behavior. Hyperproliferating fibroblasts with
overexpressed Hsp70 and TGF-𝛽 might lead to this clinical
characteristic of keloids.
Hsp70 is also known to stimulate the synthesis and secre-
tion of proinflammatorymediators such as TNF-𝛼, IL-1𝛽, and
iNOS during wound healing process [30–32]. Furthermore,
overexpression of Hsp70 in response to hypoxic injury
is known to induce the expression of TGF-𝛽1 isoforms
[33, 34]. Cao et al. [33] reported that the overexpression
of Hsp70 induces the expression of TGF-𝛽 isoforms in
keloid fibroblasts, causing excessive synthesis and deposition
of extracellular matrix. However, other investigators have
reported that Hsp70 might inhibit TGF-𝛽 signaling, partially
dependent or independent of Hsp90 activity [35]. In our
study, TGF-𝛽 was overexpressed in keloids in the same
manner as Hsp70. However, it is currently unclear whether
the overexpressed Hsp70 observed in keloids is a causative
factor or a consequence of overproduced TGF-𝛽.
Cellular skeleton associated proteins, such as tropomy-
osin and vimentin, were identified from the proteome map.
These proteins are involved in the stabilization of intracellular
skeletal components such as actin and play roles in the main-
tenance of cell shape and cell migration [36, 37]. Prosomal
P27K protein, which is not expressed in keloid fibroblasts, is
involved in the regulation of cell differentiation and the cell
cycle. Also, because of the proteolytic activity of this protein,
it is involved in protein degradation [38, 39].
5. Conclusion
We found severalHsp70 familymolecular chaperone proteins
increased in keloid fibroblasts than in normal fibroblasts
with proteomics analysis. Overexpression of Hsp70 in keloid
fibroblasts was confirmed by western blot, RT-PCR, and
immunohistochemistry. We suggested that the overexpres-
sion of Hsp70 may be involved in excessive collagen produc-
tion and deposition of keloids. The possible mechanism of
overexpressed Hsp70 in keloids can be categorized into three
areas: (1) the apoptotic pathway, (2) proinflammatory fibrob-
lasts cytokines and growth factors, (3) and TGF-𝛽. However,
in which step Hsp70 affects the keloid formation was not
investigated in this study. Therefore, further investigation
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Figure 3: Immunohistochemical staining of keloids and adjacent normal dermal tissues. Abnormal dense collagen fibers (arrow heads) were
extending over clinical keloid margin (arrow). Hsp70 and TGF-𝛽 were also increased along with extending collagen fibers (×100 and ×400).
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Figure 4: Quantitative analysis of Hsp70 protein expression. The immunohistochemical study (𝑛 = 4) showed that Hsp70 expression within
the deep dermal layer of keloid tissues was higher than in the normal adjacent dermis. The increased expression of Hsp70 in the extending
region and central keloid region was quantitatively measured with MetaMorph image analysis software (Universal Image Corp.) and was
statistically significant compared to the adjacent normal area. N, normal; E, extending region; K, keloid region (×200, ∗𝑃 < 0.001).
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Figure 5: Central keloid region and histologically revealed extend-
ing area showed increased PCNA staining. N, normal; E, extending
region; K, keloid region.
using neutralizing antibodies against Hsp70 or siRNA-Hsp70
will be needed and is currently being pursued.
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